INTENT Biologics Receives FDA Fast Track Designation for PEP Biologic™

INTENT Biologics, a clinical-stage biotechnology company developing first-in-class exosome-based biologic therapies for serious conditions with significant unmet medical need, announced today that the ...
Le Lézard

INTENT Biologics Receives FDA Fast Track Designation for PEP Biologictm

INTENT Biologics, a clinical-stage biotechnology company developing first-in-class exosome-based biologic therapies for serious conditions with significant unmet medical need, announced today that the ...

BioLab Holdings Announces Significant Team Growth Across Key Departments

BioLab Holdings, Inc. is proud to share its continued expansion and commitment to creating jobs and improving economic impact ...

Humacyte Announces Hospital Charge Data Showing High Expense of Preventable Extremity Arterial Injury Complications

Data is from comprehensive review of hospital charges and all-payer claims over five years - - Preventable complications such as amputation and ...

HMP Global Advances Wound Care Innovation Through WCCC Summit At 2026 SAWC Spring WHS

HMP Global Advances Wound Care Innovation Through WCCC Summit At 2026 SAWC Spring WHS. EINPresswire/ -- Progress in wound care accelerates when innovation, regulation, science, and clinical practice ...